Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A dystonia characterized by autosomal dominant inheritance of attacks of dystonic or choreathetotic movements precipitated by stress, fatigue, coffee or alcohol intake or menstruation that has material basis in variation in the chromosome region 2q31.
Features include sometimes findings: Migraine. 3 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Paroxysmal dystonia, Seizure, Migraine |
Biomarker and diagnostic research for paroxysmal nonkinesigenic dyskinesia 2 has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
155 publications have been identified in PubMed for paroxysmal nonkinesigenic dyskinesia 2. Research spans Basic Science / Preclinical (27%), Epidemiology / Natural History (21%), and Clinical Trial Publication (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 42 |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:47 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Disease patterns and progression | 33 | 21% |
Clinical study results | 31 | 20% |
Research summaries | 21 | 14% |
Patient case studies | 20 | 13% |
Testing and diagnosis research | 6 | 4% |
New treatment approaches | 2 | 1% |
Zhou X (2026). [PMID: 41668699](https://pubmed.ncbi.nlm.nih.gov/41668699/). *Front Neurol*. [Clinical Trial Publication]
Wang Q (2026). [PMID: 41391423](https://pubmed.ncbi.nlm.nih.gov/41391423/). *Seizure*. [Epidemiology / Natural History]
Verriello L (2026). [PMID: 41483253](https://pubmed.ncbi.nlm.nih.gov/41483253/). *Neurol Sci*. [Clinical Trial Publication]
Lumsden DE (2026). [PMID: 41093365](https://pubmed.ncbi.nlm.nih.gov/41093365/). *Archives of disease in childhood*. [Clinical Trial Publication]
Chen C (2026). [PMID: 42005633](https://pubmed.ncbi.nlm.nih.gov/42005633/). *Health Sci Rep*. [Epidemiology / Natural History]
Martinez-Valbuena I (2026). [PMID: 42157002](https://pubmed.ncbi.nlm.nih.gov/42157002/). *Nat Med*. [Diagnostic / Biomarker]
Lott E (2026). [PMID: 41223735](https://pubmed.ncbi.nlm.nih.gov/41223735/). *Pediatr Neurol*. [Basic Science / Preclinical]
Tarrano C (2026). [PMID: 41552991](https://pubmed.ncbi.nlm.nih.gov/41552991/). *Mov Disord*. [Basic Science / Preclinical]
Vijayaraghavan A (2026). [PMID: 41717889](https://pubmed.ncbi.nlm.nih.gov/41717889/). *Ann Indian Acad Neurol*. [Case Report / Case Series]
Bernardi K (2026). [PMID: 41850905](https://pubmed.ncbi.nlm.nih.gov/41850905/). *Mov Disord*. [Epidemiology / Natural History]